España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
MoonLake
MLTX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$52.17
0.29
0.56%
At close: -
$52.17
0.00
0.00%
After Hours: Dec 20, 4:00 PM EDT
Get Report
Comment
MoonLake (MLTX) Forecast
News
Earnings
MoonLake (MLTX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for MoonLake (NASDAQ:MLTX) Stock
MoonLake Stock (NASDAQ: MLTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 14, 2024
HC Wainwright & Co. Reiterates Buy on MoonLak...
Benzinga Newsdesk
Wednesday, November 13, 2024
MoonLake Immunotherapeutics Screens First Pat...
Benzinga Newsdesk
Friday, November 08, 2024
HC Wainwright & Co. Reiterates Buy on MoonLak...
Benzinga Newsdesk
Tuesday, November 05, 2024
Wedbush Assumes MoonLake at Outperform, Lower...
Benzinga Newsdesk
Tuesday, October 15, 2024
HC Wainwright & Co. Reiterates Buy on MoonLak...
Benzinga Newsdesk
Monday, September 23, 2024
Cantor Fitzgerald Reiterates Overweight on Mo...
Benzinga Newsdesk
Thursday, September 12, 2024
HC Wainwright & Co. Reiterates Buy on MoonLak...
Benzinga Newsdesk
Needham Reiterates Buy on MoonLake, Maintains...
Benzinga Newsdesk
Monday, September 09, 2024
Cantor Fitzgerald Reiterates Overweight on Mo...
Benzinga Newsdesk
Monday, August 26, 2024
Wolfe Research Downgrades MoonLake to Peer Pe...
Benzinga Newsdesk
Thursday, August 08, 2024
Needham Maintains Buy on MoonLake, Lowers Pri...
Benzinga Newsdesk
Wednesday, August 07, 2024
MoonLake Q2 2024 Adj EPS $(0.39) Misses $(0.2...
Benzinga Newsdesk
Monday, July 01, 2024
HC Wainwright & Co. Reiterates Buy on MoonLak...
Benzinga Newsdesk
Tuesday, June 25, 2024
Oppenheimer Initiates Coverage On MoonLake wi...
Benzinga Newsdesk
Tuesday, June 11, 2024
HC Wainwright & Co. Reiterates Buy on MoonLak...
Benzinga Newsdesk
Monday, June 10, 2024
Needham Reiterates Buy on MoonLake, Maintains...
Benzinga Newsdesk
MoonLake Immunotherapeutics Says FDA And EMA ...
Benzinga Newsdesk
Friday, May 17, 2024
HC Wainwright & Co. Reiterates Buy on MoonLak...
Benzinga Newsdesk
Thursday, May 16, 2024
Moonlake Immunotherapeutics Begins Phase 3 VE...
Benzinga Newsdesk
Friday, May 10, 2024
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Wednesday, May 08, 2024
HC Wainwright & Co. Reiterates Buy on MoonLak...
Benzinga Newsdesk
Needham Reiterates Buy on MoonLake, Maintains...
Benzinga Newsdesk
Tuesday, May 07, 2024
MoonLake Q1 EPS $(0.22) Misses $(0.20) Estima...
Benzinga Newsdesk
Tuesday, April 23, 2024
HC Wainwright & Co. Reiterates Buy on MoonLak...
Benzinga Newsdesk
Thursday, April 11, 2024
HC Wainwright & Co. Reiterates Buy on MoonLak...
Benzinga Newsdesk
Wednesday, April 10, 2024
Moonlake Immunotherapeutics Penned Three-year...
Benzinga Newsdesk
Tuesday, April 09, 2024
Needham Reiterates Buy on MoonLake, Maintains...
Benzinga Newsdesk
Tuesday, April 02, 2024
Goldman Sachs Initiates Coverage On MoonLake ...
Benzinga Newsdesk
Thursday, March 28, 2024
Watching MoonLake Immunotherapeutics; Shares ...
Benzinga Newsdesk
Wednesday, March 13, 2024
Wedbush Reiterates Outperform on MoonLake, Ma...
Benzinga Newsdesk
Monday, March 11, 2024
Why Is Inflammatory Disease-Focused MoonLake Immunotherapeutics Stock Trading Higher Today?
Vandana Singh
Wedbush Reiterates Outperform on MoonLake, Ma...
Benzinga Newsdesk
MoonLake Immunotherapeutics shares are tradin...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on MoonLake...
Benzinga Newsdesk
Needham Reiterates Buy on MoonLake, Maintains...
Benzinga Newsdesk
Sunday, MoonLake Immunotherapeutics Said Cont...
Benzinga Newsdesk
Monday, March 04, 2024
Moonlake Immunotherapeutics To Present Mira T...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on MoonLak...
Benzinga Newsdesk
Friday, March 01, 2024
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Wedbush Reiterates Outperform on MoonLake, Ma...
Benzinga Newsdesk
Needham Reiterates Buy on MoonLake, Maintains...
Benzinga Newsdesk
Monday, February 26, 2024
MoonLake Immunotherapeutics Announces FDA And...
Benzinga Newsdesk
Thursday, February 15, 2024
Wolfe Research Initiates Coverage On MoonLake...
Benzinga Newsdesk
Wednesday, December 20, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Monday, December 18, 2023
Stifel Maintains Buy on MoonLake, Raises Pric...
Benzinga Newsdesk
Friday, December 08, 2023
MoonLake Immunotherapeutics shares are tradin...
Benzinga Newsdesk
Citigroup Initiates Coverage On MoonLake with...
Benzinga Newsdesk
Tuesday, December 05, 2023
Watching MoonLake Immunotherapeutics; Traders...
Benzinga Newsdesk
Friday, December 01, 2023
Wedbush Reiterates Outperform on MoonLake, Ma...
Benzinga Newsdesk
Monday, November 27, 2023
Expert Ratings for MoonLake
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch